Panos C.

Panos C. has extensive experience in the biotechnology and pharmaceutical industry. Panos'smost recent position was as the Chief Development Officer at Morphocell Technologies. Prior to this, Panos co-founded and served as a director for weCANdev Consulting Group Inc and Cell & Gene Tx Stealth Co.

Before these entrepreneurial endeavors, Panos held several leadership roles at Artisan Biotechnologies, where they worked on process and analytical development for cell therapy. In this role, they led cross-functional teams and established new sites.

Panos also gained experience at BlueRock Therapeutics as an Associate Director and Senior Scientist, focusing on process development and team management. Panos was responsible for optimizing and scaling up processes for cell-based therapies.

Earlier in their career, Panos worked as a Development Scientist at CCRM, leading the cell therapy media development program. Panos also worked as a Postdoctoral Research Fellow at Griffith University, where they conducted research on drug discovery using native mass spectrometry.

Panos has a strong academic background, including a PhD in Biomedical Engineering and research roles at both Griffith University and The University of Queensland. At The University of Queensland, they worked on metabolomics and proteomics of mammalian cells, providing services to researchers and contributing to publications.

Before their research career, Panos worked as a Research Assistant at ICEHT/FORTH Patras in Greece.

Overall, Panos C. has a diverse background in biotechnology and pharmaceuticals, with experience in leadership, research, process development, and consulting.

Panos C. completed their Bachelor of Science degree in Biology/Biological Sciences at the University of Patras from 2000 to 2005. Panos then pursued a Doctor of Philosophy (Ph.D.) in Biomedical Engineering at The University of Queensland from 2010 to 2015.